I was speaking to a friend after reading the last CEO presentation and I said to him that I couldn't imagine there would be an analyst or fund manager in the audience who wouldn't want to buy shares for themselves or their clients after seeing that presentation.
The huge capital expenditure that the company undertook earlier this year when ordering new equipment is now being put to work on different mine sites across Australia and there is still equipment to come. This is also evident in their monthly revenues to date. The last figure was a record for the company.
The presentation also gave important information on the DSA purchase which has huge growth possibilities across Australia and was bought for a bargain price. The cross selling opportunities between the two companies are exciting for investors.
I would have liked to see more information on the work RQL is currently performing in Japan with Bechtel although perhaps we will see this in the end of year results presentation.
- Forums
- ASX - By Stock
- RQL
- chart
chart, page-3
Featured News
Add RQL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online